Temporal pattern of cysteine endopeptidase (cathepsin B) expression in cartilage and synovium from rabbit knees with experimental osteoarthritis: Gene expression in chondrocytes in response to interleukin-1 and matrix depletion

Annals of the Rheumatic Diseases

Volumn 56, Issue 2, 1997, Pages 108-113

  Mehraban, Fuad ^a   Tindal, Michael H ^b   Proffitt, Michelle M ^b   Moskowitz, Roland W ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PROCTER AND GAMBLE PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN B; INTERLEUKIN 1BETA;

ANIMAL EXPERIMENT; ARTICLE; CARTILAGE CELL; CONTROLLED STUDY; GENE EXPRESSION; KNEE OSTEOARTHRITIS; PRIORITY JOURNAL; SYNOVIUM;

EID: 0030943690     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.56.2.108     Document Type: Article

References (26)

1. Dean DD, Martel-Pelletier J, Pelletier J-P, Howell DS, Woessner JJF. Evidence for metalloproteinase and metalloproteinase inhibitor (TIMP) imbalance in human osteoarthritic cartilage. J Clin Invest 1989;84:678-85.
2. Fosang AJ, Neame PJ, Last K, Hardingham T , Murphy G. The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinase and cathepsin B. J Biol Chem 1992; 267:19470-4.
3. Buck MR, Karustis DJ, Day NA, Honn KV, Sloane BF. Degradation of extracellular matrix proteins by human cathepsin B from normal and tumor tissues. Biochem J 1992;282:273-8.
4. Murphy G, Cockett MI, Stephens PE, Smith BJ, Docherty AJP. Stromelysin is an activator of procollagenase. Biochem J 1987;248:265-8.
5. Maciewicz RA, Wolton SF, Etherington DJ, Duance VC. Susceptibility of the cartilage collagens types II, IX and XI to degradation by the cysteine proteinases, cathepsin B and L. FEBS Lett 1990;269:189-93.
6. Nguyen Q, Liu J, Roughley PJ, Mort JS. Link protein as a monitor in situ of endogenous proteolysis in adult human articular cartilage. Biochem J 1991;278:143-7.
7. Martel-Pelletier J, Cloutier JM, Pelletier J-P. Cathepsin B and cysteine protease inhibitors in human osteoarthritis. J Orthop Res 1990;8:336-44.
8. Baici A, Horler D, Lang A, Merlin C, Kissling R. Cathepsin B in osteoarthritis: zonal variation of enzyme activity in human femoral head. Annals Rheum Dis 1995;54:281-8.
9. Baici A, Lang A, Horler D, Kissling R, Merlin C. Cathepsin B in osteoarthritis: cytochemical and histochemical analysis of human femoral head cartilage. Ann Rheum Dis 1995;54:289-97.
10. Buttle DJ, Handley CJ, Ilic MZ, Saklatvala J, Murata M, Barrett AJ. Inhibition of cartilage proteoglycan release by a specific inactivator of cathepsin B and inhibitor of matrix metalloproteases. Arthritis Rheum 1993;36:1709-17.
11. Esser RE, Angelo RA, Murphey MD, Watts LM, Thornburg LP, Palmer JT, et al. Cysteine proteinase inhibitors decrease articular cartilage and bone destruction in chronic inflammatory arthritis. Arthritis Rheum 1994; 37:236-47.
12. Baici A, Lang A. Effect of interleukin-1 on the production of cathepsin B by rabbit articular chondrocytes. FEBS Lett 1990;277:93-6.
13. Huet G, Flipo RM, Colin C, Janin A, Hemon B, Hooghe M, et al. Stimulation of the secretion of latent cysteine proteinase activity by tumor necrosis factor-α and interleukin-1. Arthritis Rheum 1993;36:772-80.
14. Buttle DJ, Saklatvala J. Lysosomal cysteine endopeptidases mediate interleukin-1 stimulated cartilage proteoglycan degradation. Biochem J 1992;287:657-61.
15. Moskowitz RW, Davis W, Sammarco J, Martens M, Baker J, Mayer M, et al. Experimentally induced degenerative joint lesions following partial meniscectomy in the rabbit. Arthritis Rheum 1973;16:397-405.
16. Chan SJ, Segundo BS, McCormick MB, Steiner DF. Nucleotide and predicted amino acid sequences of cloned human and mouse preprocathepsin B cDNAs. Proc Natl Acad Sci USA 1986;83:7721-5.
17. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain terminating inhibitors. Proc Natl Acad Sci USA 1977;74:5463-7.
18. Mehraban F, Kuo S-Y, Riera H, Chang C, Moskowitz RW. Prostromelysin and procollagenase genes are differentially up-regulated in chondrocyts from the knees of rabbits with experimental osteoarthritis. Arthritis Rheum 1994; 37:1189-97.
19. Gong Q, Chan SJ, Bajkowski AS, Steiner DF, Frankfater A. Characterization of the cathepsin B gene and multiple mRNAs in human tissues: evidence for alternative splicing of cathepsin B pre-mRNA. DNA Cell Biol 1993;12:299-309.
20. Woessner JF, Gunja-Smith Z. Role of metalloproteinases in human osteoarthritis. J Rheumatol (suppl) 1991;27:99-101.
21. Etherington DJ. Proteinases in connective tissue breakdown. Ciba Foundation Symposium 1979;87-103.
22. Wilhelm SM, Shao ZH, Housley TJ, Seperack PK, Baumann AP, Gunja Smith Z, et al. Matrix metalloproteinase-3 (stromelysin-1). Identification as the cartilage acid metalloprotease and effect of pH on catalytic properties and calcium affinity. J Biol Chem 1993; 268:21906-13.
23. Murphy G, Ward R, Gavrilovic J, Atkinson S. Physiological mechanisms of metalloproteinase activation. Matrix 1992; suppl 1:224-30.
24. Burnett D, Abrahamson M, Devalia JL, Sapsford RJ, Davies RJ, Buttle DJ. Synthesis and secretion of procathepsin B and cystatin C by human bronchial epithelial cells in vitro: modulation of cathepsin B activity by neutrophil elastase. Arch Biochem Biophys 1995;317:305-10.
25. Werle B, Ebert W, Klein W, Spiess E. Cathepsin B in tumors, normal tissue and isolated cells from the human lung. Anticancer Res 1994;14:1169-76.
26. Baici A, Lang A, Horler D, Knopfel M. Cathepsin B as a marker of the dedifferentiated chondrocyte phenotype. Ann Rheum Dis 1988;47:684-91.